(Q42497491)

1 November 2017

title

Methylprednisolone ameliorates cochlear nerve degeneration following mechanical injury (English)

1 reference

1 November 2017

1 reference

1 reference

Sekiya T

1

1 reference

1 November 2017

Shimamura N

series ordinal

2

1 reference

1 November 2017

Suzuki S

series ordinal

3

1 reference

1 November 2017

Hatayama T

series ordinal

4

1 reference

1 November 2017

publication date

1 January 2001

1 reference

1 November 2017

1 reference

1 November 2017

volume

151

1 reference

1 November 2017

issue

1-2

1 reference

1 November 2017

page(s)

125-132

1 reference

Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Acute inflammatory response in spinal cord following impact injury

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Methylprednisolone in spinal cord injury: the possible mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Histopathology of temporal bone fractures: implications for cochlear implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Long-term effects of methylprednisolone following transection of adult rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Macrophages and inflammation in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Hearing losses following partial section of the cochlear nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Cochlear nerve injuries caused by cerebellopontine angle manipulations. An electrophysiological and morphological study in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

An in vivo quantifiable model of cochlear neuronal degeneration induced by central process injury

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Effectiveness of preoperative administration of an N-methyl-D-aspartate antagonist to enhance cochlear neuron resistance to intraoperative traumatic stress: an experimental study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Cytotoxic Effect of Brain Macrophages on Developing.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2800%2900219-7

7 January 2021

10.1016/S0378-5955(00)00219-7

Identifiers

DOI

1 reference

1 November 2017

1 reference